• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Pharmacy Research
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 9 (2025)
Volume Volume 8 (2024)
Volume Volume 7 (2023)
Volume Volume 6 (2022)
Volume Volume 5 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2020)
Volume Volume 3 (2019)
Volume Volume 2 (2018)
Volume Volume 1 (2017)
Hassan, Z., Ahmed, M., Sanad, H., Ali, A. (2021). Effect of COVID-19 on Hemoglobin: Theories and Recommended Drugs. Journal of Advanced Pharmacy Research, 5(4), 377-386. doi: 10.21608/aprh.2021.79803.1134
Zeinab A. Hassan; Mohamed H. Ahmed; Hend H. Sanad; Ahmed S. Ali. "Effect of COVID-19 on Hemoglobin: Theories and Recommended Drugs". Journal of Advanced Pharmacy Research, 5, 4, 2021, 377-386. doi: 10.21608/aprh.2021.79803.1134
Hassan, Z., Ahmed, M., Sanad, H., Ali, A. (2021). 'Effect of COVID-19 on Hemoglobin: Theories and Recommended Drugs', Journal of Advanced Pharmacy Research, 5(4), pp. 377-386. doi: 10.21608/aprh.2021.79803.1134
Hassan, Z., Ahmed, M., Sanad, H., Ali, A. Effect of COVID-19 on Hemoglobin: Theories and Recommended Drugs. Journal of Advanced Pharmacy Research, 2021; 5(4): 377-386. doi: 10.21608/aprh.2021.79803.1134

Effect of COVID-19 on Hemoglobin: Theories and Recommended Drugs

Article 3, Volume 5, Issue 4, October 2021, Page 377-386  XML PDF (345.9 K)
Document Type: Review Article
DOI: 10.21608/aprh.2021.79803.1134
View on SCiNiTO View on SCiNiTO
Authors
Zeinab A. Hassan; Mohamed H. Ahmed; Hend H. Sanad; Ahmed S. Aliorcid
Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Cairo, Helwan, Egypt.
Abstract
COVID-19 has affected over 110 million patients worldwide till February 2021. Scientists seek to understand the pathophysiology and proposed several theories. COVID-19 severe clinical phenomena occurred due to cytokine storms that cause hypochlorous acid (HOCl) production. HOCl has several harmful effects on hemoglobin, like heme degradation and iron overload toxicity. There are two theories about the attack of COVID-19 on Hemoglobin. One widely shared hypothesis based on the docking model, recommended that SARS-CoV-2 proteins ORF1ab and ORF3a bind to hemoglobin protein, changing heme to ORF10, resulting in the breakdown of the heme into iron and Protoporphyrin IX (PPIX), causing the loss of hemoglobin function and iron toxicity. Objection theory depends on comparing the experimental analysis between patients with COVID-19 and acute respiratory distress syndrome (ARDS) patients. The results showed that COVID-19 patients were not showing any hemolytic anemia or altering the hemoglobin-oxygen dissociation curve and hence, COVID-19 has no role in the removal of iron and oxygen delivery. In addition, there is a hypothesis that hemoglobin structure plays a role in the physiopathology of COVID- 19 disease. In children a high fetal hemoglobin levels leading to a decrease in the mortality rate with COVID-19. Another hypothesis linked between the blood grouping and the risk of developing COVID-19 infection.  O group persons have a lower chance for infection. From all the previous studies, many drugs formulated like fetal hemoglobin inducers, Iron chelators, and Lactoferrin represents options for the treatment of COVID-19. The present review is an attempt to describe some hypothesizes related to the Hemoglobin theory. I n addition to information about some new therapies used in the treatment of COVID-19.
Keywords
Hemoglobin; COVID-19; Iron chelators
Main Subjects
Section B: Pharmaceutical Analytical & Organic Chemistry, Medicinal & Biochemistry
Statistics
Article View: 634
PDF Download: 590
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.